Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
ANG Lifesciences India Ltd - Announcement under Regulation 30 (LODR)-Acquisition
Download announcement < Back
24 Nov 2021
Pursuant to Regulation 30 of SEBI (Listing Obligation &amp; Disclosure Requirements), 2015, we would like to inform you that the Company&apos;s Board of Directors in their meeting held on 23-Nov-2021, has decided to invest in the equity shares of ANG Healthcare India Private Limited. Therefore consequent to the acquisition of 100% Equity stake by the company, ANG Healthcare India Private Limited will become Wholly-Owned Subsidiary Company of ANG Lifesciences India Limited.&lt;BR&gt; &lt;BR&gt; ANG Healthcare India Private Limited is a marketing company selling critical care products to Hospitals and Nursing Homes in therapeutic segments of anti-biotic, anti-infective, anti-malarial, pain management etc. The company has got presence all over India through a network of Super Stockists and 150 Stockists along with a strong sales force of about 60 personnel and expanding at a fast pace. &lt;BR&gt; &lt;BR&gt;
View all announcements for ANG Lifesciences India Ltd Source: BSE India

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips